Skip to content
10-Q

Quarterly Report

Avant Diagnostics, Inc

0001493152-18-017042

← back to feed
Filed
Dec 4, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Sep 28, 2018 336.96M sh
Stockholders Equity Q3 2017 · Jun 30, 2017 $1.91M
Stockholders Equity Q3 2017 · Sep 30, 2016 $3.56M
Current Liabilities Q3 2017 · Jun 30, 2017 $3.72M
Current Liabilities Q3 2017 · Sep 30, 2016 $2.12M
Total Liabilities Q3 2017 · Jun 30, 2017 $3.72M
Total Liabilities Q3 2017 · Sep 30, 2016 $2.12M
Current Assets Q3 2017 · Jun 30, 2017 $88.19K
Current Assets Q3 2017 · Sep 30, 2016 $42.23K
Total Assets Q3 2017 · Jun 30, 2017 $5.63M
Total Assets Q3 2017 · Sep 30, 2016 $5.68M
Operating Cash Flow Q3 2017 · Jun 30, 2016 −$430.4K
Cash And Equivalents Q3 2017 · Jun 30, 2016 $126.58K
Cash And Equivalents Q3 2017 · Sep 30, 2015 $43.64K
Sga Expense Q3 2017 · Jun 30, 2016 $475.43K
Sga Expense Q3 2017 · Jun 30, 2016 $780.74K
Net Income Q3 2017 · Jun 30, 2016 −$10.89M
Net Income Q3 2017 · Jun 30, 2016 −$11.32M
Operating Income Q3 2017 · Jun 30, 2016 −$10.61M
Operating Income Q3 2017 · Jun 30, 2016 −$11.04M
Gross Profit Q3 2017 · Jun 30, 2016 $38.77K
Gross Profit Q3 2017 · Jun 30, 2016 $38.77K
Cost Of Revenue Q3 2017 · Jun 30, 2016 $52.76K
Cost Of Revenue Q3 2017 · Jun 30, 2016 $52.76K
Revenue Q3 2017 · Jun 30, 2016 $91.53K
Revenue Q3 2017 · Jun 30, 2016 $91.53K